| A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections AA Agyeman, PJ Bergen, GG Rao, RL Nation, CB Landersdorfer International journal of antimicrobial agents 55 (1), 105833, 2020 | 103 | 2020 |
| Therapeutic drug monitoring can improve linezolid dosing regimens in current clinical practice: a review of linezolid pharmacokinetics and pharmacodynamics GG Rao, R Konicki, D Cattaneo, JW Alffenaar, DJE Marriott, M Neely, ... Therapeutic drug monitoring 42 (1), 83-92, 2020 | 82 | 2020 |
| Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ... Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015 | 81 | 2015 |
| Precision dosing: public health need, proposed framework, and anticipated impact D Gonzalez, GG Rao, SC Bailey, KLR Brouwer, Y Cao, DJ Crona, ... Clinical and translational science 10 (6), 443, 2017 | 76 | 2017 |
| Personalizing polymyxin B dosing using an adaptive feedback control algorithm EA Lakota, CB Landersdorfer, RL Nation, J Li, KS Kaye, GG Rao, ... Antimicrobial agents and chemotherapy 62 (7), 10.1128/aac. 00483-18, 2018 | 71 | 2018 |
| Development of a minimal physiologically-based pharmacokinetic model to simulate lung exposure in humans following oral administration of ivermectin for COVID-19 drug repurposing B Jermain, PO Hanafin, Y Cao, A Lifschitz, C Lanusse, GG Rao Journal of pharmaceutical sciences 109 (12), 3574-3578, 2020 | 59 | 2020 |
| Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review DM Jacobs, MC Safir, D Huang, F Minhaj, A Parker, GG Rao Annals of clinical microbiology and antimicrobials 16, 1-12, 2017 | 56 | 2017 |
| Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes R Sharma, S Patel, C Abboud, J Diep, NS Ly, JM Pogue, KS Kaye, J Li, ... International journal of antimicrobial agents 49 (2), 224-232, 2017 | 56 | 2017 |
| Paradoxical effect of polymyxin B: high drug exposure amplifies resistance in Acinetobacter baumannii BT Tsuji, CB Landersdorfer, JR Lenhard, SE Cheah, V Thamlikitkul, ... Antimicrobial Agents and Chemotherapy 60 (7), 3913-3920, 2016 | 55 | 2016 |
| Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care–based collaboration model SV Monte, EM Slazak, NP Albanese, M Adelman, G Rao, JA Paladino Journal of the American Pharmacists Association 49 (2), 200-208, 2009 | 46 | 2009 |
| Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia V Perera, AS Gross, T M Polasek, Y Qin, G Rao, A Forrest, J Xu, ... Expert Opinion on Drug Metabolism & Toxicology 9 (9), 1115-1137, 2013 | 43 | 2013 |
| Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies GG Rao, NS Ly, JB Bulitta, RL Soon, MD San Roman, PN Holden, ... Journal of Antimicrobial Chemotherapy 71 (11), 3148-3156, 2016 | 42 | 2016 |
| Polymyxin B in combination with rifampin and meropenem against polymyxin B-resistant KPC-producing Klebsiella pneumoniae JK Diep, DM Jacobs, R Sharma, J Covelli, DR Bowers, TA Russo, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 02121-16, 2017 | 41 | 2017 |
| New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease GG Rao, NS Ly, CE Haas, S Garonzik, A Forrest, JB Bulitta, PA Kelchlin, ... Antimicrobial agents and chemotherapy 58 (3), 1381-1388, 2014 | 41 | 2014 |
| Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study YW Lin, RY Chang, GG Rao, B Jermain, ML Han, JX Zhao, K Chen, ... Clinical Microbiology and Infection 26 (9), 1229-1235, 2020 | 38 | 2020 |
| Assessment and modelling of antibacterial combination regimens GG Rao, J Li, SM Garonzik, RL Nation, A Forrest Clinical Microbiology and Infection 24 (7), 689-696, 2018 | 37 | 2018 |
| Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii GG Rao, NS Ly, J Diep, A Forrest, JB Bulitta, PN Holden, RL Nation, J Li, ... International journal of antimicrobial agents 48 (3), 331-336, 2016 | 34 | 2016 |
| Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid JGC van Hasselt, ML Rizk, M Lala, C Chavez‐Eng, SAG Visser, ... British Journal of Clinical Pharmacology 81 (6), 1113-1123, 2016 | 34 | 2016 |
| Impact of antibiotic resistance on treatment of pneumococcal disease in Ethiopia: an agent-based modeling simulation HH Chen, A Stringer, T Eguale, GG Rao, S Ozawa The American journal of tropical medicine and hygiene 101 (5), 1042, 2019 | 29 | 2019 |
| A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans PO Hanafin, B Jermain, AJ Hickey, AV Kabanov, ADM Kashuba, ... CPT: pharmacometrics & systems pharmacology 10 (2), 89-99, 2021 | 28 | 2021 |
Jian LiMonash University在 monash.edu 的电子邮件经过验证
